Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 9
2004 4
2005 6
2006 9
2007 13
2008 13
2009 7
2010 7
2011 6
2012 16
2013 7
2014 5
2015 10
2016 12
2017 7
2018 9
2019 13
2020 8
2021 8
2022 12
2023 21
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Preface.
Prakash C. Prakash C. Curr Drug Metab. 2015;16(1):2. doi: 10.2174/138920021601150702155640. Curr Drug Metab. 2015. PMID: 26366444 No abstract available.
Primary prevention in psychiatry--adult populations.
Brenner R, Madhusoodanan S, Puttichanda S, Chandra P. Brenner R, et al. Among authors: chandra p. Ann Clin Psychiatry. 2010 Nov;22(4):239-48. Ann Clin Psychiatry. 2010. PMID: 21180655 Review.
Metabolism of bioconjugate therapeutics: why, when, and how?
Liu H, Bolleddula J, Nichols A, Tang L, Zhao Z, Prakash C. Liu H, et al. Among authors: prakash c. Drug Metab Rev. 2020 Feb;52(1):66-124. doi: 10.1080/03602532.2020.1716784. Epub 2020 Feb 11. Drug Metab Rev. 2020. PMID: 32045530 Review.
185 results